Jun Gu

5.4k total citations · 1 hit paper
123 papers, 3.8k citations indexed

About

Jun Gu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Jun Gu has authored 123 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 25 papers in Cardiology and Cardiovascular Medicine and 22 papers in Surgery. Recurrent topics in Jun Gu's work include Atrial Fibrillation Management and Outcomes (10 papers), Cell death mechanisms and regulation (9 papers) and Epigenetics and DNA Methylation (9 papers). Jun Gu is often cited by papers focused on Atrial Fibrillation Management and Outcomes (10 papers), Cell death mechanisms and regulation (9 papers) and Epigenetics and DNA Methylation (9 papers). Jun Gu collaborates with scholars based in China, United States and Sweden. Jun Gu's co-authors include Changqian Wang, Jianguo Chen, Yingbin Liu, Wei Hu, Jianan Pan, Fang Wang, Junfeng Zhang, Ping Dong, Xiangsong Wu and Jianhua Lu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Chemistry.

In The Last Decade

Jun Gu

119 papers receiving 3.8k citations

Hit Papers

Irisin ameliorates doxorubicin-induced cardiac perivascul... 2021 2026 2022 2024 2021 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells
    2021 142 citations Jianan Pan, Hao Lin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Gu China 39 1.9k 643 634 606 429 123 3.8k
Guang Liang China 40 2.3k 1.2× 421 0.7× 529 0.8× 428 0.7× 364 0.8× 129 4.7k
Lei Zhao China 27 1.1k 0.6× 584 0.9× 520 0.8× 305 0.5× 374 0.9× 103 2.9k
Li Chu China 33 1.4k 0.8× 475 0.7× 271 0.4× 656 1.1× 236 0.6× 189 3.5k
Anjana Munshi India 31 1.1k 0.6× 377 0.6× 459 0.7× 415 0.7× 245 0.6× 157 2.9k
Zoltán V. Varga Hungary 34 1.4k 0.8× 1.0k 1.6× 425 0.7× 343 0.6× 444 1.0× 115 4.0k
Shaoyu Zhou China 30 1.7k 0.9× 381 0.6× 707 1.1× 339 0.6× 159 0.4× 57 3.2k
Wei Deng China 40 3.0k 1.6× 1.4k 2.1× 874 1.4× 614 1.0× 507 1.2× 151 5.8k
Colin J. Meyer United States 34 3.2k 1.7× 385 0.6× 268 0.4× 310 0.5× 371 0.9× 82 5.2k
Ming‐Zhi Zhang United States 38 1.5k 0.8× 596 0.9× 283 0.4× 325 0.5× 337 0.8× 83 4.1k
Shuangxi Wang China 30 1.3k 0.7× 450 0.7× 360 0.6× 177 0.3× 431 1.0× 93 3.2k

Countries citing papers authored by Jun Gu

Since Specialization
Citations

This map shows the geographic impact of Jun Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Gu more than expected).

Fields of papers citing papers by Jun Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Gu. The network helps show where Jun Gu may publish in the future.

Co-authorship network of co-authors of Jun Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Gu. A scholar is included among the top collaborators of Jun Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Gu. Jun Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Qing, et al.. (2025). Cardiotoxicity associated with antineoplastic agents: a pharmacovigilance study based on FDA adverse event reporting system. Therapeutic Advances in Drug Safety. 16. 1601853346–1601853346.
2.
3.
Sun, Xingwei, Hao Zhang, Jun Gu, et al.. (2024). Microspheres-mediated magnetic thermal ablation combined with immune checkpoint blockade therapy for liver cancer. Chemical Engineering Journal. 497. 154574–154574. 3 indexed citations
4.
5.
Pan, Jianan, et al.. (2021). MiR‐21‐3p Inhibits Adipose Browning by Targeting FGFR1 and Aggravates Atrial Fibrosis in Diabetes. Oxidative Medicine and Cellular Longevity. 2021(1). 9987219–9987219. 17 indexed citations
6.
Chen, Kan, Yuqi Fan, Jun Gu, et al.. (2021). Effect of lgals3a on embryo development of zebrafish. Transgenic Research. 30(6). 739–750. 1 indexed citations
7.
Bi, Xinling, Li Zhou, Yanfang Liu, Jun Gu, & Qing‐Sheng Mi. (2021). MicroRNA-146a Deficiency Delays Wound Healing in Normal and Diabetic Mice. Advances in Wound Care. 11(1). 19–27. 33 indexed citations
8.
Liang, Weitao, Jun Gu, Xueshan Zhao, et al.. (2019). Comparative transcriptome analysis to elucidate the therapeutic mechanism of colchicine against atrial fibrillation. Biomedicine & Pharmacotherapy. 119. 109422–109422. 18 indexed citations
9.
Gu, Jun. (2019). Visit-to-visit variability in LDL-cholesterol is associated with adverse events in non-obstructive coronary artery disease. The Anatolian Journal of Cardiology. 22(3). 117–124. 4 indexed citations
10.
Wang, Yue, et al.. (2017). Cordycepin induces apoptosis of human acute monocytic leukemia cells via downregulation of the ERK/Akt signaling pathway. Experimental and Therapeutic Medicine. 14(4). 3067–3073. 12 indexed citations
11.
Wang, Yuqin, Shiyan Yan, Feng Shen, et al.. (2016). Type 2 diabetes and gender differences in liver cancer by considering different confounding factors: a meta-analysis of cohort studies. Annals of Epidemiology. 26(11). 764–772. 18 indexed citations
12.
Gu, Jun, et al.. (2014). RNAi-mediated silencing of ATP-binding cassette C4 protein inhibits cell growth in MGC80-3 gastric cancer cell lines.. PubMed. 60(1). 1–5. 6 indexed citations
13.
Ma, Kelong, Xiaorong Pan, Pingsheng Fan, et al.. (2014). Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells. Molecular Cancer. 13(1). 118–118. 62 indexed citations
14.
Li, Maolan, Wenguang Wu, Jiasheng Mu, et al.. (2013). The role of prophylactic transpapillary pancreatic stenting in distal pancreatectomy: a meta-analysis. Frontiers of Medicine. 7(4). 499–505. 11 indexed citations
15.
Li, Maolan, Songgang Li, Wenguang Wu, et al.. (2012). [Differential gene expression profiles of gastric cancer].. PubMed. 92(18). 1249–52. 1 indexed citations
16.
Wang, Xuefeng, Jiawei Mei, Wenjie Zhang, et al.. (2010). Endoscopic retrograde cholangiopancreatography after Billroth II gastrectomy. Zhonghua xiaohua neijing zazhi. 27(9). 451–453. 2 indexed citations
17.
Wang, Wei, Lili Zheng, Fang Wang, et al.. (2010). Tanshinone IIA attenuates neuronal damage and the impairment of long-term potentiation induced by hydrogen peroxide. Journal of Ethnopharmacology. 134(1). 147–155. 37 indexed citations
18.
Liu, Chao, Jiliang Wu, Kui Xu, et al.. (2009). Neuroprotection by baicalein in ischemic brain injury involves PTEN/AKT pathway. Journal of Neurochemistry. 112(6). 1500–1512. 135 indexed citations
19.
20.
Zhu, Weiming, Ning Li, Jianan Ren, et al.. (2002). Rehabilitation therapy for short bowel syndrome.. PubMed. 115(5). 776–8. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guang Liang Breakdown of academic impact, for papers by Lei Zhao Breakdown of academic impact, for papers by Li Chu Breakdown of academic impact, for papers by Anjana Munshi Breakdown of academic impact, for papers by Zoltán V. Varga Breakdown of academic impact, for papers by Shaoyu Zhou Breakdown of academic impact, for papers by Wei Deng Breakdown of academic impact, for papers by Colin J. Meyer Breakdown of academic impact, for papers by Ming‐Zhi Zhang Breakdown of academic impact, for papers by Shuangxi Wang
Rankless by CCL
2026